Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

559 ARTÍCULOS , VIENDO DEL 31 AL 45

The Role of the JAK/STAT Signaling Pathway in the Pathogenesis of Alzheimer's Disease: New Potential Treatment Target

Rusek M, Smith J, El-Khatib K, Aikins K, Czuczwar SJ, Pluta R.

Int J Mol Sci. 2023 Jan 3;24(1):864. doi: 10.3390/ijms24010864.

Pharmacogenetics of anxiety and depression in Alzheimer's disease

Cacabelos R, Carril JC, Corzo L, Pego R, Cacabelos N, Alcaraz M, Muñiz A, Martínez-Iglesias O, Naidoo V.

Pharmacogenomics. 2023 Jan;24(1):27-57. doi: 10.2217/pgs-2022-0137. Epub 2023 Jan 11.

Impact of nanoparticles on amyloid β-induced Alzheimer's disease, tuberculosis, leprosy and cancer: a systematic review

Chakraborty A, Mohapatra SS, Barik S, Roy I, Gupta B, Biswas A.

Biosci Rep. 2023 Feb 27;43(2):BSR20220324. doi: 10.1042/BSR20220324.

The measured CSF/plasma donepezil concentration ratio but not individually measured CSF and plasma concentrations significantly increase over 24 h after donepezil treatment in patients with Alzheimer's disease

Valis M, Dlabkova A, Hort J, Angelucci F, Pejchal J, Kuca K, Pavelek Z, Karasova JZ, Novotny M.

Biomed Pharmacother. 2023 Mar;159:114223. doi: 10.1016/j.biopha.2023.114223. Epub 2023 Jan 9.

Photobiomodulation for Alzheimer's disease: photoelectric coupling effect on attenuating Aβ neurotoxicity

Tian Z, Wang P, Huang K, Yu J, Zhang M, Liu Y, Zhao H, Zhu B, Huang X, Tong Z.

Lasers Med Sci. 2023 Jan 12;38(1):39. doi: 10.1007/s10103-022-03692-z.

Hyperphosphorylated tau (p-tau) and drug discovery in the context of Alzheimer's disease and related tauopathies

Moore KBE, Hung TJ, Fortin JS.

Drug Discov Today. 2023 Mar;28(3):103487. doi: 10.1016/j.drudis.2023.103487. Epub 2023 Jan 9.

TREM2 signalling as a multifaceted player in brain homoeostasis and a potential target for Alzheimer's disease treatment

Ayyubova G.

Eur J Neurosci. 2023 Feb;57(4):718-733. doi: 10.1111/ejn.15914. Epub 2023 Jan 29.

Cannabinoids in neuroinflammatory disorders: Focusing on multiple sclerosis, Parkinsons, and Alzheimers diseases

Abd-Nikfarjam B, Dolati-Somarin A, Baradaran Rahimi V, Askari VR.

Biofactors. 2023 May-Jun;49(3):560-583. doi: 10.1002/biof.1936. Epub 2023 Jan 13.

Role of angiotensin receptor blockers in the context of Alzheimer's disease

Kuber B, Fadnavis M, Chatterjee B.

Fundam Clin Pharmacol. 2023 Jun;37(3):429-445. doi: 10.1111/fcp.12872. Epub 2023 Jan 26.

Oral THC: CBD cannabis extract in main symptoms of Alzheimer disease: agitation and weight loss

Palmieri B, Vadalà M.

Clin Ter. 2023 Jan-Feb;174(1):53-60. doi: 10.7417/CT.2023.5009.

Application of Marine Natural Products against Alzheimer's Disease: Past, Present and Future

Hu D, Jin Y, Hou X, Zhu Y, Chen D, Tai J, Chen Q, Shi C, Ye J, Wu M, Zhang H, Lu Y.

Mar Drugs. 2023 Jan 5;21(1):43. doi: 10.3390/md21010043.

Metal Complexes as Promising Matrix Metalloproteinases Regulators

Nguyen YT, Kim N, Lee HJ.

Int J Mol Sci. 2023 Jan 9;24(2):1258. doi: 10.3390/ijms24021258.

Tacrine-Based Hybrids: Past, Present, and Future

Bubley A, Erofeev A, Gorelkin P, Beloglazkina E, Majouga A, Krasnovskaya O.

Int J Mol Sci. 2023 Jan 15;24(2):1717. doi: 10.3390/ijms24021717.

Combined metabolic activators improve cognitive functions in Alzheimer's disease patients: a randomised, double-blinded, placebo-controlled phase-II trial

Yulug B, Altay O, Li X, Hanoglu L, Cankaya S, Lam S, Velioglu HA, Yang H, Coskun E, Idil E, Nogaylar R, Ozsimsek A, Bayram C, Bolat I, Oner S, Tozlu OO, Arslan ME, Hacimuftuoglu A, Yildirim S, Arif M, Shoaie S, Zhang C, Nielsen J, Turkez H, Borén J, Uhlén M, Mardinoglu A.

Transl Neurodegener. 2023 Jan 26;12(1):4. doi: 10.1186/s40035-023-00336-2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias